Dr. Ip Pun Ching Philip - Pathology
Specialist in Pathology
Highlights
- MCHK RegisteredVerified
- Specialist in PathologyBachelor of Medicine and Bachelor of Surgery, University of Glasgow · Member of the Royal College of Pathologists · The Hong Kong College of Pathologists · Medical degree 1992
- InsuranceBeing compiled｜See details
About
Dr. Ip Pun Ching Philip is a registered Pathology specialist in Hong Kong.
Education
Specialist in Pathology
- Bachelor of Medicine and Bachelor of Surgery, University of GlasgowBachelor of Medicine and Bachelor of Surgery, University of Glasgow1992
- Member of the Royal College of PathologistsMember of the Royal College of Pathologists2001
Hong Kong Academy of Medicine fellowships
- FHKCPathFellow, The Hong Kong College of Pathologists
Source: Hong Kong Academy of Medicine Fellows Register, checked 12 Sep 2026
Insurance
Insurance plans being compiled
We're collecting insurance plan data per clinic. For confirmation, contact the clinic directly.
Are you Dr. Ip Pun Ching Philip? Claim page and update insurance →
FAQ
Is Dr. Ip Pun Ching Philip any good?
Dr. Ip Pun Ching Philip is a registered Pathology specialist in Hong Kong. Qualifications and registration come from the Hong Kong Medical Council. ok.med does not rate or rank doctors.
What does Dr. Ip Pun Ching Philip do?
Dr. Ip Pun Ching Philip practises in Pathology.
Are you Dr. Ip Pun Ching Philip? Claim this page to update and manage.
ClaimResearch and publications
35 papers · 12 most recent shown
Filter by paper topic
Topics come from medical classifications on these PubMed papers, not from the doctor's listed services.
- Endometrial Carcinomas With a Somatically Derived Yolk Sac Tumor Component Share Molecular Similarities to p53-abnormal Endometrial Carcinomas and Germ Cell Tumors.Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc · 2026
- Effects of thyroiditis on the diagnostic performance of fine-needle aspiration cytology- clinico-radiologico-cytological analysis of risk factors for discordance.BMC endocrine disorders · 2026
- Subclonal β-catenin/YAP signaling heterogeneity accelerates ovarian cancer metastasis through a senescence-associated secretory phenotype.Cell death & disease · 2026
- P-cadherin mechanoactivates tumor-mesothelium metabolic coupling to promote ovarian cancer metastasis.Cell reports · 2025
- Bola-Amphiphilic Dendrimer Enhances Imatinib to Target Metastatic Ovarian Cancer via β-Catenin-HRP2 Signaling Axis.ACS applied materials & interfaces · 2025
- CT-based radiomics model to predict platinum sensitivity in epithelial ovarian carcinoma: a multicentre study.Cancer imaging : the official publication of the International Cancer Imaging Society · 2025
- Dynamin 1-mediated endocytic recycling of glycosylated N-cadherin sustains the plastic mesenchymal state to promote ovarian cancer metastasis.Protein & cell · 2025
- Digital image analysis of gland-to-stroma ratio by CD10 objectively differentiates between low-grade endometrioid carcinoma and atypical hyperplasia on endometrial biopsy.Pathology · 2025
- The Malignant Potential of Ovarian Steroid Cell Tumors Revisited: A Multi-institutional Clinicopathologic Analysis of 115 Cases.The American journal of surgical pathology · 2024
- The Value of Four-Quadrant Cervical Biopsy in Women with Different Colposcopic Impressions.Diagnostics (Basel, Switzerland) · 2023
- A Selective β-Catenin-Metadherin/CEACAM1-CCL3 Axis Mediates Metastatic Heterogeneity upon Tumor-Macrophage Interaction.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2022
- DEPDC1B Promotes Melanoma Angiogenesis and Metastasis through Sequestration of Ubiquitin Ligase CDC16 to Stabilize Secreted SCUBE3.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2022
Publication data comes from PubMed / Europe PMC and is matched automatically by name and affiliation. Every entry links to the source.
For reference only. Not medical advice. Read full disclaimer